BrightGene Bio-Medical Technology Co.,Ltd.

About BrightGene Bio-Medical Technology Co.,Ltd.

BrightGene Bio-medical Technology Co Ltd is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. 

We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis....

  • CN
  • 2015
    On CPHI since
Contact info
  • Room C26-C27, Suzhou biological nano-technology park, No.218 Xinghu Street, 215123, Suzhou, China
Meet us at

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 June 2024 - 21 June 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from BrightGene Bio-Medical Technology Co.,Ltd. (5)

  • MMAF

    Product MMAF

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • MMAE

    Product MMAE

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • Maytansinol

    Product Maytansinol

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-4

    Product DM-4

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-1

    Product DM-1

    • Status: Validated • Usage:  Antibody-drug Conjugate